neogenomics inc (neo) - medical equipment - deals and alliances profile

Date: July 12, 2018
Pages: 36
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: N7C2329D171EN
Leaflet:

Download PDF Leaflet

neogenomics inc (neo) - medical equipment - deals and alliances profile
Summary

NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers diagnostic, prognostic and predictive testing services. The company offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry, and molecular genetics including sanger sequencing and fragment analysis. It also offers APvX, LIS/EMR integration and tech-only services. NeoGenomics’s biopharma services support drug development programs ranging from early biomarker discovery to clinical trials. The company caters to oncologists, pathologists, pharmaceutical companies, academic centers, and others. It operates through its subsidiaries. NeoGenomics is headquartered in Fort Myers, Florida, the US.

neogenomics inc (neo) - medical equipment - deals and alliances profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.

NOTE: Out of security concerns GlobalData requires using corporate email address.
NeoGenomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
NeoGenomics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018
NeoGenomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
NeoGenomics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018
NeoGenomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
NeoGenomics Inc, Medical Equipment, Deal Details
Partnerships
Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker
Health Discovery Enters Into Licensing Agreement With NeoGenomics
NeoGenomics and Definiens Enter into Agreement
Arno Therapeutics Enters Into Co-Development Agreement With Clarient Diagnostic Services
Qiagen Enters Into Agreement With Clarient To Offer therascreen KRAS RGQ PCR Kit
Equity Offering
NeoGenomics Raises USD37 Million in Public Offering of Shares
NeoGenomics Completes Public Offering Of Shares For US$10 Million
Acquisition
NeoGenomics Acquires Clarient from GE Healthcare
NeoGenomics Inc - Key Competitors
NeoGenomics Inc - Key Employees
NeoGenomics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Jun 01, 2018: PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions
Nov 09, 2017: NeoGenomics Europe Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials
Financial Announcements
May 01, 2018: NeoGenomics Reports Revenue of $63.4 Million, Net Income of $0.6 Million and Adjusted EBITDA of $9.2 Million in the First Quarter of 2018
Feb 21, 2018: NeoGenomics Reports Revenue of $67.8 Million on 18.7% Clinical Volume Growth and $10.5 Million of Adjusted EBITDA in the Fourth Quarter of 2017
Jul 25, 2017: NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017
Apr 26, 2017: NeoGenomics Reports 15% Volume Growth and 10% Reduction in Average Cost per Test in the First Quarter of 2017
Feb 22, 2017: NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016
Corporate Communications
Mar 20, 2018: NeoGenomics Announces Executive Appointments
Apr 20, 2017: NeoGenomics Appoints Bill Bonello as Vice President, Treasurer, and Director of Corporate Development
Product News
Jun 02, 2017: NeoGenomics Announces Expansion of Immuno-Oncology Profiling Tests
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

NeoGenomics Inc, Medical Equipment, Key Facts, 2017
NeoGenomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
NeoGenomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
NeoGenomics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018
NeoGenomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
NeoGenomics Inc, Deals By Market, 2012 to YTD 2018
NeoGenomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker
Health Discovery Enters Into Licensing Agreement With NeoGenomics
NeoGenomics and Definiens Enter into Agreement
Arno Therapeutics Enters Into Co-Development Agreement With Clarient Diagnostic Services
Qiagen Enters Into Agreement With Clarient To Offer therascreen KRAS RGQ PCR Kit
NeoGenomics Raises USD37 Million in Public Offering of Shares
NeoGenomics Completes Public Offering Of Shares For US$10 Million
NeoGenomics Acquires Clarient from GE Healthcare
NeoGenomics Inc, Key Competitors
NeoGenomics Inc, Key Employees
NeoGenomics Inc, Other Locations
NeoGenomics Inc, Subsidiaries

LIST OF FIGURES

NeoGenomics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
NeoGenomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
NeoGenomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
NeoGenomics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018
NeoGenomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
NeoGenomics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
NeoGenomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
NeoGenomics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018
Skip to top


Ask Your Question

neogenomics inc (neo) - medical equipment - deals and alliances profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: